FDA recall, , Moderate risk
Boston Scientific Neuromodulation TCD Electrodes
TCD Electrodes may have small cut marks on the sterile pouch, which could cause contamination and lead to infection.
What happened
Boston Scientific Neuromodulation Corporation, of Valencia, California, has voluntarily recalled several models of its TCD Electrodes. The company started the recall on its own on October 5, 2026. The agency says radiofrequency probes may have small cut marks on the Tyvek side of the sterile pouch.
If the sterile barrier is compromised and the devices are used, microbial or other foreign material could be introduced into patient tissue. The agency says this may lead to infection, pain, inflammation, allergic reaction, toxicity, or the need for additional medical or surgical intervention.
The recalled products are TCD Electrodes in 5cm, 10cm and 15cm sizes, including versions with a 3M Cable. The recall covers distribution across the United States, including 42 states and territories. The FDA classified the recall on November 6, 2026. The recall is in FDA's weekly enforcement report, dated November 18, 2026.
What to do
If a code on your device is listed below:
- Check the lot against the recall notice and ask your provider or supplier before you stop using it.
Typical advice for a recalled medical device; the FDA notice gives no product-specific instructions.
Is yours affected?
Match the UDI-DI and lot code listed under your product.
A UDI-DI is the device identifier printed with the barcode on the device label.
TCD Electrodes (Description/REF(Inner/Outer))
- UDI-DI
- 00813250014396
- Lot code
- TCD-10-3M
- 39749333
- 85009822
Recall details
- Posted by FDA
- Recall began
- Status
- Open
- Weekly archive
- Listed the week of Nov 2, 2026
- Sold in
Distributed in Ohio, Idaho, Kentucky, New Jersey, Georgia, New York, Missouri, South Carolina, Minnesota, Iowa, Michigan, Massachusetts, Wisconsin, Texas, Maine, Indiana, Arkansas, Colorado, Illinois, Vermont, Virginia, Mississippi, Washington, Oregon, Nevada, Arizona, Utah, Florida, Wyoming, California, Oklahoma, North Carolina, Tennessee, Maryland, Delaware, Louisiana, Hawaii, Connecticut, West Virginia, Alabama, New Hampshire and North Dakota.
- Recalled by
- Boston Scientific Neuromodulation CorporationValencia, California
- Hazard
- Sterility problem · Contamination · Foreign object
- Risk
Moderate risk
Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- FDA event number
- 100005
- Recall number
- Z-0368-2027
- Recall type
- Started by the company
All recalls from Boston Scientific Neuromodulation Corporation
Timeline
FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.
Boston Scientific Neuromodulation Corporation began the recall
FDA posted the recall to its Enforcement Report and rated it Class II (moderate risk)
Added to Recall Canary



